Johnson & Johnson Operating Expenses 2010-2025 | JNJ

Johnson & Johnson operating expenses for the twelve months ending March 31, 2025 were $62.727B, a 4.36% decline year-over-year.

  • Johnson & Johnson annual operating expenses for 2024 were $72.134B, a 2.91% increase from 2023.
  • Johnson & Johnson annual operating expenses for 2023 were $70.097B, a 15.61% increase from 2022.
  • Johnson & Johnson annual operating expenses for 2022 were $60.631B, a 1.79% increase from 2021.

Johnson & Johnson Operating Expenses 2010-2025 | JNJ

  • Johnson & Johnson annual operating expenses for 2024 were $72.134B, a 2.91% increase from 2023.
  • Johnson & Johnson annual operating expenses for 2023 were $70.097B, a 15.61% increase from 2022.
  • Johnson & Johnson annual operating expenses for 2022 were $60.631B, a 1.79% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B